Hydrocision, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$540Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
778clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Dominic King | Cleveland, OH | Sports Medicine (Family Medicine) | $183,335.21 |
| Jason Genin | Lorain, OH | Sports Medicine (Family Medicine) | $88,793.59 |
| Nathan Holmes | Sewell, NJ | Sports Medicine (Family Medicine) | $53,270.92 |
| Christopher Varacallo | Du Bois, PA | Family Medicine | $40,403.25 |
| Michael Dakkak | Weston, FL | Sports Medicine (Family Medicine) | $30,308.25 |
| Timothy Murphy | East Providence, RI | Vascular & Interventional Radiology | $16,719.50 |
| Timothy Gardner | Lebanon, NH | Gastroenterology (Internal Medicine) | $7,800.00 |
| David Lindley | Mineral Wells, TX | Interventional Pain Medicine | $7,584.53 |
| Frederic Gerges | Boston, MA | Interventional Pain Medicine | $7,543.75 |
| Paul Hubbell | Metairie, LA | Interventional Pain Medicine | $5,976.16 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.